Embracing Future Holdings Limited

Embracing Future Holdings Limited a precision medicine medical technology company focuses on developing a portfolio of diagnostic solutions in Japan Hong Kong Thailand Malaysia and the United States It operates through Cancer Infectious Diseases and Laboratory Services segments The company offers ClearCell FX1 System that includes Streck Cellfree DNA BCT and EDTA tubes a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells or CTCs from small amounts of blood and CTChip FR1 biochip that isolate the CTCs from leukocytes It also provides laboratory services The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025 The company was incorporated in 2009 and is based in Singapore